low-molecular-weight heparins (Lovenox, Fragmin) for treating unstable angina and non-Q-wave MIs
December 1999
The American Heart Assoc and American College of Cardiology now recommend low-molecular-weight heparins (Lovenox, Fragmin) for treating unstable angina and non-Q-wave MIs.
They can be used as an alternative to unfractionated heparin.
In fact, Lovenox (enoxaparin) seems to be MORE effective than standard heparin for reducing the risk of MI and death.
Get concise, unbiased advice for effective drug therapy, plus CE/CME
Prescriber's Letter includes:
- 12 issues every year, with brief articles about new meds and guidelines
- 48+ CE courses, including the popular CE-in-the-Letter
- Quick reference drug comparison charts
- Access to the entire archive
Already a subscriber? Log in
Volume pricing available. Get a quote